After viral infection of INS-1 832/13 cells, we validated their efficacy by showing that both GSK3β-specific shRNA sequences efficiently decreased mRNA levels of GSK3β, without alterating the levels of GSK3α mRNAs (Fig. 6C). The gene discussed is GSK3A; the disease is viral infectious disease.